Hemashield M002020851680Recalls & reported problems
Intervascular Sas · Hemashield Gold Knitted Microvel Bifurcated Double Velour Vascular Graft with Graft Sizer Accessory · Class 2 · Implant
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 3
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00384401017721), received between Mar 10, 2017 and May 25, 2026 — classified as 3 injuries, 1 malfunction.
The most frequently reported specific device problem is “Insufficient Device Problem Information” (2 reports).
6 other recalls cover devices cleared under the same FDA submission (K954848); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Reports received per month
Most reported problems
Device problems
- Insufficient Device Problem Information2
- Hole In Material1
- Inaccurate Information1
Patient problems
- Bacterial Infection2
- Blood Loss1
- No Clinical Signs, Symptoms or Conditions1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
InjuryMay 25, 2026Insufficient Device Problem Information
THIS EVENT WAS SUBMITTED AS PART OF THE INTERVASCULAR PMCF REGISTRY. ON (B)(6) 2016, THE PATIENT PRESENTED WITH A LESION IN THE EXTERNAL AND COMMON ILIAC ARTERIES OF THE BILATERAL LOWER EXTREMITIES. A HEMASHIELD GOLD KNITTED MICROVEL DOUBLE VELOUR VASCULAR GRAFT WAS SOAKED IN HEPARIN BEFORE THE PROCEDURE, AND THE GRAFT WAS IMPLANTED VIA AORTOBIILIAC BYPASS WITHOUT ANY ISSUES. TECHNICAL SUCCESS WAS ACHIEVED AND THE PATIENT WAS DISCHARGED ON (B)(6) 2016. ON (B)(6) 2016, 4 MONTHS AND 11 DAYS AFTER THE INITIAL IMPLANT PROCEDURE, THE PATIENT EXPERIENCED A MAJOR ADVERSE LIMB EVENT (INFECTION). THE SEVERITY WAS NOTED AS SEVERE AND THE INVESTIGATOR NOTED THIS WAS CAUSALLY RELATED TO THE STUDY PROCEDURE AND CAUSALLY RELATED TO THE DEVICE. AN INTERVENTIONAL TREATMENT (SURGICAL PROCEDURE) WAS PERFORMED AND THIS ADVERSE EVENT IS NOTED AS RECOVERED WITH SEQUELAE. A SURGICAL PROCEDURE INCLUDING AXILLO-BIFEMORAL BYPASS, REMOVAL OF AORTIC GRAFT, REDO OF AXILLO-BIFEMORAL BYPASS WAS PERFORMED WITH GRAFT REINTERVENTION BUT NO AMPUTATION. THE CLINIC PROVIDED THE FOLLOWING DETAILS, "ON (B)(6) 2016 SUBJECT PRESENTED WITH FEVER, CHILLS, TACHYCARDIAC AND HYPOTENSIVE, COMPUTED TOMOGRAPHY SCAN REVEALED POSS
Patient problems: Bacterial Infection
MAUDE report 25267650 ↗InjuryMay 22, 2026Insufficient Device Problem Information
THIS EVENT WAS SUBMITTED AS PART OF THE INTERVASCULAR PMCF REGISTRY. ON (B)(6) 2016, THE PATIENT PRESENTED WITH A LESION IN THE EXTERNAL AND COMMON ILIAC ARTERIES OF THE BILATERAL LOWER EXTREMITIES. A HEMASHIELD GOLD KNITTED MICROVEL DOUBLE VELOUR VASCULAR GRAFT WAS SOAKED IN HEPARIN BEFORE THE PROCEDURE, AND THE GRAFT WAS IMPLANTED VIA AORTOBIILIAC BYPASS WITHOUT ANY ISSUES. TECHNICAL SUCCESS WAS ACHIEVED AND THE PATIENT WAS DISCHARGED ON (B)(6) 2016. ON (B)(6) 2016, 4 MONTHS AND 11 DAYS AFTER THE INITIAL IMPLANT PROCEDURE, THE PATIENT EXPERIENCED A MAJOR ADVERSE LIMB EVENT (INFECTION). THE SEVERITY WAS NOTED AS SEVERE AND THE INVESTIGATOR NOTED THIS WAS CAUSALLY RELATED TO THE STUDY PROCEDURE AND CAUSALLY RELATED TO THE DEVICE. AN INTERVENTIONAL TREATMENT (SURGICAL PROCEDURE) WAS PERFORMED AND THIS ADVERSE EVENT IS NOTED AS RECOVERED WITH SEQUELAE. A SURGICAL PROCEDURE INCLUDING AXILLO-BIFEMORAL BYPASS, REMOVAL OF AORTIC GRAFT, REDO OF AXILLO-BIFEMORAL BYPASS WAS PERFORMED WITH GRAFT REINTERVENTION BUT NO AMPUTATION. THE CLINIC PROVIDED THE FOLLOWING DETAILS, "ON (B)(6) 2016 SUBJECT PRESENTED WITH FEVER, CHILLS, TACHYCARDIAC AND HYPOTENSIVE, COMPUTED TOMOGRAPHY SCAN REVEALED POSS
Patient problems: Bacterial Infection
MAUDE report 25256086 ↗MalfunctionOct 15, 2021Inaccurate Information; Inaccurate Information
COMPLAINT # (B)(4). SEE MFG REPORT NUMBER 1640201-2021-00034.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 12638005 ↗InjuryMar 10, 2017Hole In Material; Hole In Material
IT WAS REPORTED THAT ON (B)(6) 2017, DURING A VASCULAR SURGERY, AFTER SUTURING THE PROXIMAL PORTION AND DECLAMPING THE GRAFT, A SMALL PIN HOLE AT THE BIFURCATION OF THE GRAFT WAS NOTICED, CAUSING SOME WEEPING. THE PHYSICIAN TOOK A 5.0 PROLENE SUTURE AND REPAIRED THE HOLE, THE GRAFT REMAINED IMPLANTED. THE SURGERY WAS COMPLETED WITHOUT ANY ADVERSE CONSEQUENCE FOR THE PATIENT.
Patient problems: Blood Loss
MAUDE report 6394682 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K954848. One submission often covers many models, so check the product and lot details in each record.
- Z-0729-2022 · Jan 14, 2022 · TerminatedHEMASHIELD GOLD KNITTED MICROVEL DOUBLE VELOUR VASCULAR GRAFT- D: 7 mm; L: 60 cm Indicated for use in the replacement or repair of arteries affected with aneurysmal or occlusive
- Z-0403-2022 · Dec 1, 2021 · TerminatedHemashield Gold Knitted Bifurcated, 18 mm x 9 mm; reference number M002020851890
- Z-1859-2020 · Apr 7, 2020 · TerminatedHemashield Gold Knitted Microvel Double Velour Vascular Graft-Axillo-bifemoral, Product Code: M002020955010 - Product Usage: For use in the replacement or repair of arteries affect
- Z-1860-2020 · Apr 7, 2020 · TerminatedHemashield Gold Knitted Microvel Double Velour Vascular Graft-Axillo-bifemoral, Product Code: M002020955880 - Product Usage: for use in the replacement or repair of arteries affect
- Z-1861-2020 · Apr 7, 2020 · TerminatedHemashield Gold Knitted Microvel Double Velour Vascular Graft Axillo-bifemoral, Product Code: M002020955890 - Product Usage: for use in the replacement or repair of arteries affect
- Z-2066-2010 · May 24, 2010 · TerminatedHemashield Gold Woven and Knitted Double Vascular Grafts.
Other Graft, Vascular, Synthetic/Biologic Composite devices
- Hemashield M00202166168P0Intervascular Sas · Graft, Vascular, Synthetic/Biologic Composite1 recall3 reports
- Hemashield M002020851890Intervascular Sas · Graft, Vascular, Synthetic/Biologic Composite1 recall2 reports
- Hemashield M002020952070Intervascular Sas · Graft, Vascular, Synthetic/Biologic Composite1 recall0 reports
- Hemashield M00202175928P0Intervascular Sas · Graft, Vascular, Synthetic/Biologic Composite10 reports
- Hemashield M00202175208P0Intervascular Sas · Graft, Vascular, Synthetic/Biologic Composite8 reports
- Hemashield M00202175210P0Intervascular Sas · Graft, Vascular, Synthetic/Biologic Composite8 reports
- AlboGraft Polyester Vascular Graft AMC1407Lemaitre Vascular, Inc. · Graft, Vascular, Synthetic/Biologic Composite6 reports
- Hemashield M00202175430P0Intervascular Sas · Graft, Vascular, Synthetic/Biologic Composite6 reports
Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.